Is PMC a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

188 people get PMC articles and Market Currents by email alert.

Get email alerts on PMC »

HEADLINES:

Industry Tailwinds Give PharMerica A Long Runway For Growth
Soldier of Fortune • Wed, May 15 • 2 Comments
PharMerica to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire (May 14, 2013)
PharMerica Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
PharMerica Reports Results for the First Quarter of 2013

Business Wire (May 1, 2013)
Looking Into The Specialty Pharmacy Sector
Dutch Trader • Wed, May 1
Specialty Pharmacies: An Overlooked Segment In A Profitable Industry
Glen S. Woods • Mon, Apr 15 • 1 Comment
PharMerica Appoints David Froesel, Jr. as Interim Chief Financial Officer

Business Wire (Apr 12, 2013)
PharMerica Corporation to Broadcast First Quarter 2013 Results Conference Call Live on the Internet

Business Wire (Apr 2, 2013)
PharMerica's Management Presents at Barclays Global Healthcare Conference (Transcript)
Thu, Mar 14
PharMerica Announces Date of 2013 Annual Shareholders’ Meeting

Business Wire (Mar 12, 2013)
PharMerica to Present at the Barclays Global Healthcare Conference

Business Wire (Mar 7, 2013)
PharMerica to Present at the Cowen and Company 33rd Annual Health Care Conference

Business Wire (Feb 27, 2013)
PharMerica's Management Presents at Citi 2013 Global Healthcare Conference (Transcript)
Mon, Feb 25
PharMerica to Present at the RBC Capital Markets 2013 Healthcare Conference

Business Wire (Feb 20, 2013)
PharMerica to Present at the Citi 2013 Global Healthcare Conference

Business Wire (Feb 19, 2013)
PharMerica Management Discusses Q4 2012 Results - Earnings Call Transcript
Fri, Feb 8
PharMerica Reports Results for the Fourth Quarter of 2012 and Year Ended December 31, 2012

Business Wire (Feb 7, 2013)
PharMerica to Present at the Leerink Swann Global Healthcare 2013 Conference

Business Wire (Feb 6, 2013)
PharMerica Corporation to Broadcast Fourth Quarter and Year-End 2012 Results Conference Call Live on the Internet

Business Wire (Jan 16, 2013)
PharMerica to Present at the Noble Financial Capital Markets Ninth Annual Equity Conference

Business Wire (Jan 16, 2013)

Industry Tailwinds Give PharMerica A Long Runway For Growth
Soldier of Fortune • Wed, May 15 • 2 Comments

Industry Tailwinds Give PharMerica A Long Runway For Growth
Soldier of Fortune • Wed, May 15 • 2 Comments
Key Insider Purchases At PharMerica
Howard Ackerman • Thu, Jun 21, 2012 • 1 Comment

Looking Into The Specialty Pharmacy Sector
Dutch Trader • Wed, May 1
Specialty Pharmacies: An Overlooked Segment In A Profitable Industry
Glen S. Woods • Mon, Apr 15 • 1 Comment
6 Services Stocks Trading Near Highs Undervalued By Graham Number
Kapitall • Wed, Dec 12, 2012 • 2 Comments
3 Small Cap Growth Stocks With Positive Momentum
Arie Goren • Mon, Oct 15, 2012
6 Outperforming Services Stocks Undervalued By The Graham Number
Kapitall • Mon, Aug 27, 2012 • 3 Comments
4 Undervalued Small Cap Stocks With Cash Reserves
ZetaKap • Mon, Aug 20, 2012 • 1 Comment
Healthcare: 1 Buy And 1 Sell Ahead Of Earnings
Matt Schilling • Thu, Aug 2, 2012 • 2 Comments
Cash Rich Companies Choosing Stock Repurchases Rather Than Dividend Hikes - Part XXI
The Value Investor • Mon, Jul 9, 2012
4 Small Caps Purchased By Insiders Today
Gutone • Mon, Jun 18, 2012
10 Oversold Stocks Undervalued By The Graham Number
Kapitall • Tue, Mar 27, 2012 • 1 Comment
Discounted Stocks Or Value Traps?
Stookle • Tue, Mar 6, 2012 • 1 Comment
7 Oversold Stocks Undervalued By The Graham Number
Kapitall • Thu, Feb 9, 2012 • 1 Comment
12 Oversold Stocks Hedge Funds Are Buying Up
Kapitall • Thu, Jan 26, 2012 • 2 Comments
All Objectives Met In The $50k Challenge: 10.3% Return In Less Than 5 Days
Kinetic Investments • Sun, Jan 15, 2012 • 15 Comments
Beware Of Employment Report Fridays
Bespoke Investment Group • Sun, Jan 8, 2012 • 1 Comment
10 Undervalued Stocks With Strong Bullish Momentum
Follow My Alpha • Wed, Oct 19, 2011
Top Picks From Tuesday's Big News Movers
GuruFundPicks • Wed, Oct 5, 2011 • 1 Comment
5 Stocks Posting Big Moves On Tuesday
Alex Shadunsky • Wed, Aug 24, 2011 • 1 Comment
Contrarian Ideas: 10 Low P/FCF Stocks With Bearish Options
Kapitall • Fri, May 13, 2011
Celesio: An Undervalued Drug Wholesaler That Could Double in Price
Clemens Scholl • Tue, May 3, 2011 • 19 Comments

PharMerica Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
PharMerica's Management Presents at Barclays Global Healthcare Conference (Transcript)
Thu, Mar 14
PharMerica's Management Presents at Citi 2013 Global Healthcare Conference (Transcript)
Mon, Feb 25
PharMerica Management Discusses Q4 2012 Results - Earnings Call Transcript
Fri, Feb 8
PharMerica Corporation Q4 2008 Earnings Call Transcript
Fri, Feb 6, 2009
PharMerica Corporation Q3 2008 Earnings Call Transcript
Fri, Oct 31, 2008
PharMerica Corporation Q2 2008 Earnings Call Transcript
Sun, Aug 24, 2008
PharMerica Corporation Q1 2008 Earnings Call Transcript
Tue, May 13, 2008

PharMerica to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire (May 14, 2013)
PharMerica Reports Results for the First Quarter of 2013

Business Wire (May 1, 2013)
PharMerica Appoints David Froesel, Jr. as Interim Chief Financial Officer

Business Wire (Apr 12, 2013)
PharMerica Corporation to Broadcast First Quarter 2013 Results Conference Call Live on the Internet

Business Wire (Apr 2, 2013)
PharMerica Announces Date of 2013 Annual Shareholders’ Meeting

Business Wire (Mar 12, 2013)
PharMerica to Present at the Barclays Global Healthcare Conference

Business Wire (Mar 7, 2013)
PharMerica to Present at the Cowen and Company 33rd Annual Health Care Conference

Business Wire (Feb 27, 2013)
PharMerica to Present at the RBC Capital Markets 2013 Healthcare Conference

Business Wire (Feb 20, 2013)
PharMerica to Present at the Citi 2013 Global Healthcare Conference

Business Wire (Feb 19, 2013)
PharMerica Reports Results for the Fourth Quarter of 2012 and Year Ended December 31, 2012

Business Wire (Feb 7, 2013)
PharMerica to Present at the Leerink Swann Global Healthcare 2013 Conference

Business Wire (Feb 6, 2013)
PharMerica Corporation to Broadcast Fourth Quarter and Year-End 2012 Results Conference Call Live on the Internet

Business Wire (Jan 16, 2013)
PharMerica to Present at the Noble Financial Capital Markets Ninth Annual Equity Conference

Business Wire (Jan 16, 2013)
PharMerica Corporation Names Patrick G. LePore to Its Board of Directors

Business Wire (Jan 14, 2013)
PharMerica Corporation Acquires Amerita, Inc.

Business Wire (Dec 13, 2012)
PharMerica to Present at the Credit Suisse 2012 Healthcare Conference

Business Wire (Nov 8, 2012)
PharMerica to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

Business Wire (Nov 7, 2012)
PharMerica Reports Results for the Third Quarter of 2012 and Nine Months Ended September 30, 2012

Business Wire (Nov 1, 2012)
PharMerica Corporation to Broadcast Third Quarter 2012 Results Conference Call Live on the Internet

Business Wire (Oct 5, 2012)
PharMerica Corporation Names Mark Lindemoen Senior Vice President of Sales and Client Services

Business Wire (Sep 27, 2012)

PMC vs. ETF Alternatives

Company Description

Currently, there's no company description for PMC.

Sector: Services

Industry: Drug Stores

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 1, 5:50 PM PharMerica (PMC): Q1 EPS of $0.46 beats by $0.12. Revenue of $498.9M beats by $66.81M. (PR) Comment! [Earnings, Breaking News]
Tuesday, April 16, 5:48 PM Amgen (AMGN) has agreed to to pay $24.9M to settle allegations that it violated the False Claims Act by paying kickbacks to long-term care pharmacy providers to entice them to use its Aranesp anemia drug instead of a rival medicine. The DoJ claims the payments were made to Omnicare (OCR), PharMerica (PMC) and Kindred Healthcare (KND) in return for implementing "therapeutic interchange" programs that were designed to switch Medicare and Medicaid beneficiaries from a competitor drug to AMGN's Aranesp. Comment! [Healthcare]
Friday, April 12, 4:16 PM PharMerica (PMC) names David W. Froesel, Jr. as interim Chief Financial Officer, effective immediately. Mr. Froesel, who was CFO of Omnicare from 1996 to 2009, and succeeds Michael J. Culotta, who by mutual agreement with the company, has stepped down to pursue other interests. Shares -1.7% AH. Comment! [Healthcare, On the Move]
Monday, February 11, 12:59 PM PharMerica (PMC -3.3%) dips as RBC Capital cuts the shares to Sector Perform on valuation following last weeks earnings report, saying that the nursing home pharmacy's reached it's $15 price target and coupled with declining sales, it doesn't see any incremental catalysts for growth over the near-term. Comment! [Healthcare, On the Move]
Thursday, February 7, 5:14 PM More on PharMerica (PMC): Q4 beats across the board despite double digit declines in total sales, which were driven in part by higher generic dispensing. Cash flow provided by operating activities jumped by 220% on the dispensing increase, with over 85% of prescriptions now dispensed generically. Comment! [Healthcare, Earnings]
Thursday, February 7, 5:01 PM PharMerica (PMC): Q4 EPS of $0.33 beats by $0.04. Revenue of $433.2M (-12.6% Y/Y) beats by $0.77M. (PR) Comment! [Earnings, Breaking News]
Thursday, December 13, 2012, 4:36 PM PharMerica Corporation (PMC) acquires Amerita, a provider of specialty home infusion services with operations in Tennessee, Texas, Oklahoma, Colorado and Utah, in an all cash transaction. Amerita is a leading provider of specialty infusion services, and the purchase will allow PMC to leverage existing pharmacies and broaden its product offerings. The deal is expected to be moderately accretive to the Company in 2013. Comment! [Healthcare]
Thursday, November 1, 2012, 6:41 PM PharMerica (PMC): Q3 EPS of $0.33 beats by $0.03. Revenue of $442M (-14.8% Y/Y) misses by $4M. (PR) Comment! [Earnings]
Thursday, August 2, 2012, 6:24 PM PharMerica (PMC): Q2 EPS of $0.32 beats by $0.02. Revenue of $458M (-13.8% Y/Y) misses by $30M. (PR) Comment! [Earnings]
Monday, July 2, 2012, 4:27 PM PharMerica (PMC) announces $25M increase to its existing share repurchase program . Shares +2.2% AH. Comment! [Healthcare]
Thursday, May 3, 2012, 2:30 PM PharMerica (PMC +3.7%) moves up after beating Q1 estimates late yesterday. Total revenue actually declined 6.8% Y/Y, but margins were boosted by stronger cash flow. RBC ups the shares to Outperform on the report, citing valuation, better visibility and positive earnings growth. Comment! [Earnings, On the Move, Healthcare]
Wednesday, May 2, 2012, 6:52 PM PharMerica (PMC): Q1 EPS of $0.30 beats by $0.03. Revenue of $499M (-6.8% Y/Y) beats by $6M. Shares +0.4% AH. (PR) Comment! [Earnings]
Tuesday, February 21, 2012, 9:58 AM Omnicare (OCR -0.5%) withdraws its hostile offer for nursing-home pharmacy company PharMerica (PMC -2.6%) a month after federal regulators raised antitrust issues. PMC says it is "pleased" with the decision, believing that the offer undervalued the company; OCR says it will provide an update to strategies on Thursday, when it reports its Q4 results. Comment! [Healthcare, M&A, On the Move]
Thursday, February 9, 2012, 5:52 PM PharMerica (PMC): Q4 EPS of $0.27 beats by $0.06. Revenue of $495.6M (+0.8% Y/Y) misses by $10M. Shares +3.1% AH. (PR) Comment! [Earnings, On the Move]
Monday, January 30, 2012, 10:01 AM Though PharMerica (PMC -12.6%) remains off sharply following the FTC's decision to block Omnicare's (OCR -1.4%) hostile bid, the company says it's pleased with the move. Meanwhile, Barclays and Cowen recommend buying Omnicare on any post-FTC weakness, arguing its fundamentals are sound regardless of whether a merger occurs. Comment! [Healthcare, M&A, On the Move, Quick Ideas]
Monday, January 30, 2012, 9:00 AM Premarket gainers: PBY +25%. GTXI +24%. TNB +23%. AMLN +14%. LCC +7%. ARNA +7%. PTNR +4%.
Losers: CTIC -18%. PMC -14%. DB -6%. ING -5%. BCS -5%. MT -5%. CHU -4%. STD -4%. AKS -3%. DANG -3%. PLX -3%. PT -3%. JASO -3%. KOG -3%. X -3%. ANR -3%. RIG -3%. Comment! [On the Move]

Patrick Harden
PMC Commercial Trust (PMC) fails to find a buyer; ends strategic review. Dividend is going to be cut by 25% to $0.12/share.
10/26/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Undervalued Small Cap Stocks With Cash Reserves http://bit.ly/QRsDaA $BAS $CSH $PMC $SIM @ZetaKap
8/20/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Kinetic Investments
$XLE sell 100 @ $69.89 - been trading PMC a bit - The $50k challenge... http://bit.ly/weBbIM
1/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Kinetic Investments
$PMC - Short covering rally into the close?
1/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
PharMerica rejects Omnicare's $441 mln offer again $PMC $OCR
9/27/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dr. Kris
A risky 7%: OCR offering PMC shareholders $15/share. PMC board previously rejected same deal but is considering it now. $PMC @ $14-->7% ROI.
9/7/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
Omnicare offers to buy Pharmerica for $441 million $OCR $PMC
8/23/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
PMC - 80% Barchart.com sell signal-below 20, 50 & 100 day moving averages-14.60% off high-Relative Strength Index 39.31% and falling
3/15/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Patrick Harden
PMC Commercial Trust (PCC) looking expensive at over $9/share. Company is not currently covering dividend with taxable income.
8/8/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

EquityClock
PMC appears to have hit a strong level of support, positioning it well for a move to the upside: http://bit.ly/aKCXYJ
6/18/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

PMC PharMerica Corporation

PMC

PharMerica Corporation